Dr. Reza Entezari Heravi, Pharm.D, Ph.D of Pharmaceutical Biotechnology

Dr. Reza Entezari Heravi, Pharm.D, Ph.D of Pharmaceutical Biotechnology

<p> CVCV RezaReza Entezari Entezari Heravi, Heravi, Ph.D Ph.D (Biotechnology)(Biotechnology)</p><p>Dr. Reza Entezari Heravi, Pharm.D, Ph.D of Pharmaceutical Biotechnology, </p><p>School of Pharmacy, Mashhad University of Medical Sciences (MUMS)</p><p>Date of Birth: 18.06.1981- Tehran</p><p>Marital Status: Married</p><p>Ph.D average score: 19.03</p><p>EDUCATION</p><p>2000-2006 School of Pharmacy, Mashhad University of Medical Science</p><p>2006-2014 School of Pharmacy, Biotechnology assistant (Ph.D)</p><p>2014 till now Assistant professor in Biotechnology department, Zabol University of medical Sciences</p><p>MEMBERSHIP</p><p>1. Iranian Committee of Biotechnology</p><p>2. Iranian Committee of Genetics</p><p>3. Frankfurt Innovation Center, Max-Planck Institute, Frankfurt am Main, Germany</p><p>PROFESSIONAL EXPERIENCES</p><p>1. Epidemiological studies</p><p>2. Genetic polymorphism</p><p>3. HPLC methods</p><p>4. Drug design & Drug discovery</p><p>5. Molecular Modeling 6. Molecular Docking</p><p>7. Bioinformatics</p><p>8. Gene expression profiling</p><p>9. Transcriptome studies (cDNA Microarrays, Real-time PCR)</p><p>10. Natural anti-sense technology</p><p>11. Transgenic animals and plants</p><p>12. Cancer biomarkers</p><p>13. Teaching Molecular and Cellular Biology and Biotechnology in Azad University of Pharmacy, Tehran</p><p>14. Real-time PCR </p><p>15. Primer Design</p><p>16. Stem Cells and their differentiation </p><p>CERTIFICATES/COURSES</p><p>1. SPSS workshop, 2009</p><p>2. Transcriptome for cDNA microarray workshop, 2007</p><p>3. Six-month scholarship in Max-Planck Institute, Frankfurt Innovation Center, GenXPro, Frankfurt am Main, Germany, June 2010-January 2011 (working on Next-generation sequencing)</p><p>4. Supre-SAGE courses for cancer biomarkers, Frankfurt am Main, Germany, 2011</p><p>5. Complexity systems and Chaos theory, Santa Fe Institute, New Mexico, USA, 2014</p><p>COMPUTER SKILLS</p><p>Microsoft Office (Word, Excel, Outlook, Power Point), Photoshop, Adobe Acrobat, Endnote, ChemOffice, GenePix Microarray Software, Misc. PCR designer software, SPSS statistical analysis and among many others, NCBI methods.</p><p>RESEARCH INTERESTS</p><p>1. Epigenetic profiling of complex diseases (i.e. late-onset Alzheimer’s, cancer, PTSD) 2. Pharmacoepigenomics (drug-epigenome interactions)</p><p>3. Influence of environment (e.g. nutrition, radiation) on human health and epigenetic integrity</p><p>4. Development of epigenetic profiling methods (microarrays and nucleotide chemistry)</p><p>5. Bioinformatics</p><p>6. Cancer signaling pathways</p><p>7. Drug design for cancer therapy</p><p>8. Stem Cell differentiation</p><p>AWARDS</p><p>1. Second rank in 10th seminar of Iranian Pharmacist, Mashhad, 2003</p><p>2. First rank in all student of biotechnology, Mashhad pharmacy school, 2007</p><p>3. The Best Researcher of Mashhad University of Medical Sciences, 2009</p><p>4. The Best book translator of Mashhad University of Medical Sciences for the Book: “ Molecular Biotechnology, Bernard Glick and Jack J Pasternack”, 2009</p><p>5. Membership of Frankfurt Innovation center, GenXPro, Frankfurt am Main, Germany, 2010</p><p>6. Certificate form for working with Prof. Dr. Guenter Kahl, Johann wolfgang Goethe University for research about Natural anti-sense biomarkers in Pancreatic cancer using Super-SAGE methods</p><p>7. 93rd Canadian Chemistry Conference and Exhibition. May 29 –June 2, 2010. Toronto. Canada. Reza Entezari Heravi, Farzin Hadizadeh, Jalil Tavakol Afshari, Mojtaba Sankian and Javad Behravan. Synthesis and activity of new analogs of selecoxib as cyclooxygenase 2 (COX-2) inhibitors.</p><p>PUBLICATIONS AND ARTICLES </p><p>1. The Biotechnology reference book: Molecular Biotechnology, Bernard Glick and Jack J Pasternack, 2009 2. Book: Bioinformatic for Dummies </p><p>3. Book: Encyclopedia of Foods (In Press)</p><p>4. Association of CYP2A6*1 and CYP2A6*4 with nicotine metabolism in an Iranian population (DNA and Cell Biology)</p><p>5. Association of MDR1 gene polymorphism with gastric cancer in an ethnic Iranian population (Indian Journal of Cancer)</p><p>6. Association of MDR1 gene polymorphism with colorectal cancer in an Iranian population (Molecular Biology Reports)</p><p>7. Association of MDR1 gene polymorphism and ALL in Iranian population (Iranian Journal of Blood and Cancer)</p><p>8. Novel selective Cox-2 inhibitors induce apoptosis in Caco-2 colorectal carcinoma cell line (European Journal of Pharmaceutical Sciences)</p><p>9. Cyclooxygenase-2 inhibitors increases Bax/Bcl-2 ratio and up-regulates Caspase-3 gene expression (Genes & Genomics)</p><p>LANGUAGE</p><p>Fluent in English, Average in German</p><p>OTHER RESEARCH</p><p>1. Modeling, Design and biological evaluation of four celecoxib analogous as apoptosis inducer in colorectal cancer cell lines</p><p>2. Evaluation of four celecoxib analogous as MAP kinase inhibitors</p><p>MY THESIS </p><p>Gene expression profiling of Caco-2 colorectal cancerous cell line in response to four new analogous of celecoxib by using cDNA microarray method. Projects in Process</p><p>1. Differentiation of human adipose and bone marrow stem cells to beta-islet pancreatic cells to produce insulin.</p><p>2. Design, Modeling and Synthesis of new Histone deacetylase inhibitors as new drugs for pain relief.</p><p>Contact me:</p><p>E-mail:[email protected]</p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    5 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us